TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive NCI Programs: NCI Drug Screening To Take More Targeted Approach; BSA Okays Plan To Support New MA Contracts April 3, 1998